Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS
Open Access
- 1 January 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 290 (1) , H450-H457
- https://doi.org/10.1152/ajpheart.00472.2005
Abstract
Protection from a prolyl hydroxylase domain-containing enzyme (PHD) inhibitor, desferoxamine (DFO), was recently reported to be dependent on production of reactive oxygen species (ROS). Ischemic preconditioning triggers the protected state by stimulating nitric oxide (NO) production to open mitochondrial ATP-sensitive K+(mitoKATP) channels, generating ROS required for protection. We tested whether DFO and a second PHD inhibitor, ethyl-3,4-dihydroxybenzoate (EDHB), might have similar mechanisms. EDHB and DFO increased ROS generation by 50–75% ( P < 0.001) in isolated rabbit cardiomyocytes. This increase after EDHB exposure was blocked by Nω-nitro-l-arginine methyl ester (l-NAME), an NO synthase (NOS) inhibitor; ODQ, a guanylyl cyclase antagonist; and Rp-8-bromoguanosine-3′,5′-cyclic monophosphorothioate Rp isomer, a PKG blocker, thus implicating the NO pathway in EDHB's signaling. Glibenclamide, a nonselective KATPchannel blocker, or 5-hydroxydecanoate, a selective mitoKATPchannel antagonist, also prevented EDHB's ROS production, as did blockade of mitochondrial electron transport with myxothiazol. NOS is activated by Akt. However, neither wortmannin, an inhibitor of phosphatidylinositol-3-kinase, nor Akt inhibitor blocked EDHB-induced ROS generation, indicating that EDHB initiates signaling downstream of Akt. DFO also increased ROS production, and this effect was blocked by ODQ, 5-hydroxydecanoate, and N-(2-mercaptopropionyl)glycine, an ROS scavenger. DFO increased cardiomyocyte production of nitrite, a metabolite of NO, and this effect was blocked by an inhibitor of NOS. DFO also spared ischemic myocardium in intact hearts. This infarct-sparing effect was blocked by ODQ, l-NAME, and N-(2-mercaptopropionyl)glycine. Hence, DFO and EDHB stimulate NO-dependent activation of PKG to open mitoKATPchannels and produce ROS, which act as second messengers to trigger entrance into the preconditioned state.Keywords
This publication has 45 references indexed in Scilit:
- Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicalsFree Radical Biology & Medicine, 2005
- Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significanceEuropean Heart Journal, 2004
- Novel Mechanism of Action for HydralazineCirculation Research, 2004
- Persistent induction of HIF‐1α and ‐2α in cardiomyocytes and stromal cells of ischemic myocardiumThe FASEB Journal, 2004
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCirculation, 2003
- Acetylcholine-induced production of reactive oxygen species in adult rabbit ventricular myocytes is dependent on phosphatidylinositol 3- and Src-kinase activation and mitochondrial KATP channel openingJournal of Molecular and Cellular Cardiology, 2003
- Mitochondrial KATP channels in preconditioningJournal of Molecular and Cellular Cardiology, 2003
- Activation of the Prolyl Hydroxylase Oxygen-sensor Results in Induction of GLUT1, Heme Oxygenase-1, and Nitric-oxide Synthase Proteins and Confers Protection from Metabolic Inhibition to CardiomyocytesJournal of Biological Chemistry, 2003
- How Do Cells Sense Oxygen?Science, 2001
- Protective responses in the ischemic myocardiumJournal of Clinical Investigation, 2000